Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Diabetes

Ethnicity-associated variance in efficacy of pioglitazone as a preventive tool

Nature Reviews Endocrinology volume 5, page 355 (2009)Cite this article

Access through your institution
Buy or subscribe

Ramachandran, A. et al. Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2). Diabetologia 52, 1019–1026 (2009).

Pioglitazone therapy does not add extra benefit to lifestyle modification for prevention of type 2 diabetes mellitus in people in India who are at risk of developing the disease. This finding differs from results that were obtained in similar studies performed in the US.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Julianna Vig
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vig, J. Ethnicity-associated variance in efficacy of pioglitazone as a preventive tool. Nat Rev Endocrinol 5, 355 (2009). https://doi.org/10.1038/nrendo.2009.85

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nrendo.2009.85

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing